AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CARCLO PLC

Board/Management Information Jul 20, 2018

5252_rns_2018-07-20_a6a8cb85-7c80-4761-b6db-a46f6ac698d3.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2143V

Carclo plc

20 July 2018

20 July 2018

Carclo plc ("Carclo" or the "Company")

Board changes

Further to the announcement made on 15 January 2018, the Board confirms that Michael Derbyshire retired from the Board on 19 July 2018 and that Mark Rollins has replaced him in the role of Chairman.

Further to the announcement made on 17 April 2018, the Board confirms that Sarah Matthews-DeMers was appointed to the Carclo Board with effect from 18 July 2018 and further to the announcement made on 28 June 2018, the Board confirms that Joe Oatley was appointed to the Carclo Board with effect from 20 July 2018.

Mark Rollins, Chairman of Carclo, said: "I would like to thank Michael for his contribution to the Company and for his support in my taking over in the Chairman role. I look forward to working with the new Board to deliver the significant growth and operational efficiency opportunities that are available to Carclo over the coming years."

Enquiries:
Carclo plc 01924 268040
Chris Malley, Chief Executive
Sarah Matthews-DeMers, Finance Director
Peel Hunt LLP 0207 418 8900
Justin Jones
Sam Cann
Weber Shandwick Financial 020 7067 0700
Nick Oborne

Notes to editors

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there remain significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of Group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of Group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOALLFIEDEIALIT

Talk to a Data Expert

Have a question? We'll get back to you promptly.